⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL83101 | 1.00 | — | — | |
| SCHEMBL1592631 | 0.90 | — | — | |
| SCHEMBL944166 | 0.90 | — | — | |
| SCHEMBL1541745 | 0.90 | — | — | |
| SCHEMBL5987428 | 0.88 | — | — | |
| SCHEMBL5984987 | 0.88 | — | — | |
| SCHEMBL5986034 | 0.88 | — | — | |
| SCHEMBL5986830 | 0.88 | — | — | |
| SCHEMBL5984541 | 0.88 | — | — | |
| SCHEMBL563888 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3022199-A1 | CYANOTRIAZOLE COMPOUNDS | Otsuka Pharmaceutical Co., Ltd. (JP) | 2016-05-25 | — | — | EP | claimed |
| WO-2015008872-A1 | CYANOTRIAZOLE COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2015-01-22 | — | — | WO | claimed |
| US-6498190-B1 | TREATMENT OF NASAL OCCLUSION AND MAST CELL DYSFUNCTION DISEASES; ANTIINFLAMMATORY AGENTS | SHIONOGI & CO., LTD. (JP) | 2002-12-24 | — | — | US | claimed |
| EP-0837052-A1 | BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME | SHIONOGI & CO., LTD. (JP) | 1998-04-22 | — | — | EP | claimed |
| CN-111417627-B | Hydrogenation of Imines Using RU Complexes | 弗门尼舍有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20240197724-A1 | THERAPEUTIC AGENT FOR GAIT DISTURBANCE | NIPPON SHINYAKU CO., LTD. (JP) | 2024-06-20 | — | — | US | disclosed |
| EP-4316489-A1 | THERAPEUTIC AGENT FOR GAIT DISTURBANCE | Nippon Shinyaku Co., Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| WO-2023234426-A1 | ANTIBODY-MULTIDRUG CONJUGATE | ＵＢＥ株式会社 | 2023-12-07 | — | — | WO | disclosed |
| WO-2023234427-A1 | ANTIBODY-MULTIDRUG CONJUGATE PRECURSOR AND SYNTHETIC INTERMEDIATE THEREOF | ＵＢＥ株式会社 | 2023-12-07 | — | — | WO | disclosed |
| CN-117157075-A | Remedies for gait disorder | 日本新药株式会社 | 2023-12-01 | — | — | CN | disclosed |
| WO-2023192286-A2 | ALKENYL SUCCINIMIDE COMPOUNDS AND THEIR USE | VERTELLUS HOLDINGS LLC (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023163227-A1 | ANTIBODY-DRUG CONJUGATE | ＵＢＥ株式会社 | 2023-08-31 | — | — | WO | disclosed |
| US-4322323-A | Erodible device comprising surfactant for modifying the rate of erosion of the device | ALZA CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4180646-A | BIOERODABLE SUSTAINED RELEASE COTAINGS | ALZA CORPORATION (US) | 1979-12-25 | — | — | US | disclosed |
| US-4155992-A | SUSTAINED RELEASE | ALZA CORPORATION (US) | 1979-05-22 | — | — | US | disclosed |
| US-4138344-A | Erodible agent releasing device comprising poly(orthoesters) and poly(orthocarbonates) | ALZA CORPORATION (US) | 1979-02-06 | — | — | US | disclosed |
| US-4131648-A | POLYMERIC MATERIALS | ALZA CORPORATION (US) | 1978-12-26 | — | — | US | disclosed |
| US-4093709-A | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) | ALZA CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
| US-4079038-A | HAVING RECURRING DIOXYCARBON MOIETIES | ALZA CORPORATION (US) | 1978-03-14 | — | — | US | disclosed |
| US-4070347-A | Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality | ALZA CORPORATION (US) | 1978-01-24 | — | — | US | disclosed |